HS1, a Lyn Kinase Substrate, Is Abnormally Expressed in B-Chronic Lymphocytic Leukemia and Correlates with Response to Fludarabine-Based Regimen
Federica Frezzato(University of Padua), Livio Trentin(University of Padua)
Cited by 32
Related Papers
HSP70/HSF1 axis, regulated <i>via</i> a PI3K/AKT pathway, is a druggable target in chronic lymphocytic leukemia
|International Journal of Cancer|2019|40